Pharma's Almanac TVPA TV
 
  • Follow the Journey
  • Companies We've Met
  • AES Clean Technology
  • Altis Biosystems
  • Arranta Bio
  • Avara Pharmaceutical Services
  • Avid Bioservices
  • BioVectra
  • Centaur BPS
  • Dynamk Capital
  • ECRI
  • Evolve Biologics
  • Federal Equipment Company
  • Globyz
  • Inceptor Bio
  • IPS-Integrated Project Services
  • Olon
  • Pii
  • Polpharma Biologics
  • PPD
  • RoosterBio
  • SanaClis
  • Sanofi AIS
  • SGD Pharma
  • SPI Pharma
  • TriRx Pharmaceutical Services
  • Yourway
Dashboard
Your Name
Your Email
  • Manage Account
  • Sign Out
Sign In
Register
    • Topics
        Products
        • ADC
        • API - Small Molecule
        • Biologics
        • Biopharmaceuticals
        • Biosimilars
        • Cell and Gene Therapy
        • DNA
        • Drug Product
        • Drug Substance
        • Equipment
        • Generics
        • Immunotherapy
        • Injectables
        • Monoclonal Antibody
        • Novel Therapeutics
        • Oral Solid Dosage
        • Orphan Drugs
        • Parenterals
        • Stem Cells
        • Vaccine
        Services
        • Big Data
        • Bioprocessing
        • Clinical Trials
        • Continuous Manufacturing
        • Diagnostics
        • Drug Delivery
        • Drug Development
        • Drug Discovery
        • Facility
        • Formulation
        • Innovation
        • Oncology
        • Patient Adherence
        • Patient Centric
        • Preclinical
        • Process Development
        • Quality
        • Regulatory
        • Research
        • Serialization
        Segment
        • Biomanufacturing
        • Biotechnology
        • CDMO
        • Consulting
        • CRO
        • Engineering
        • Equipment
        • Excipients
        • Healthcare
        • Intermediates
        • Logistics
        • Manufacturing
        • Packaging
        • Supply Chain
        Business
        • Agreement
        • Appointment
        • Business
        • Capacity Expansion
        • Collaboration
        • Growth
        • Investment
        • Licensing
        • M&A
        • Market Expansion
        • Market Intelligence
        • Market Prediction
        • New Facility
        • Strategic Partnership
    • Magazine
      • Current Issue
      • Archive
    • Reports
      • Biologics Pricing Report
      • Oral Solid Dose Market Report
    • Community
    • Company A to Z
    • Content Filter
    • More+
      • Staffing
      • Media Kit
      • By The Numbers

    Gene Editing

    13 Articles Available

    Can't find what you're looking for? Try our advanced search.

    Gene Editing

    Enhancing Human Gut Tissue Models through Gene Editing
    PAO-11-20-CL-03

    CRISPR RNPs

    CRISPR RNPs and the Future of Cell and Gene Therapy
    PAP-Q3-20-CL-002

    Gene Therapy

    Slow Progress and a Shaky Start—What’s Next for Gene Therapy?
    PAP-Q4-19-NI-001

    CRISPR-Cas9

    CRISPR-Cas9 Milestones: The First In Vivo Clinical Trial Is Now Underway
    PAP-Q4-19-CL-011

    Gene Editing

    Trucode Launched to Advance Next-Generation Gene Editing Platform
    PR-M09-19-NI-027

    CRISPR

    CRISPR Gene Editing of Babies Could Take Place in Russia
    PAO-M06-19-NI-021

    Gene Editing

    China to Introduce Regulations on Gene Editing
    PAO-M05-19-NI-031

    CRISPR-Cas9

    University of California Granted New CRISPR-Cas9 Patent, Extending its Patent Portfolio for Genome Editing
    PR-M03-19-NI-040

    Cell and Gene Therapy

    Precision BioSciences Aims for Significant Funding Support based on its ARCUS Gene Editing Tech
    PAO-M03-19-NI-013

    Genome Editing

    Sangamo Announces Interim Results Of Phase 1/2 CHAMPIONS Study Showing Preliminary Evidence Of In Vivo Genome Editing In Patients With MPS II Treated With SB-913
    PR-M02-19-NI-020

    CRISPR

    MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
    PR-M09-18-NI-046

    Gene Editing

    Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems
    PAO-M11-17-NI-046

    Gene Editing

    More Gene Editing Technology Being Developed by Novartis
    PAO-M11-17-NI-043

    About Us
    That’s Nice Staffing By The Numbers
    More
    Media Kit Download Current Issue
    Your Account
    Manage Your Account Dashboard Sign Out
    Sign In Register
    Help
    Contact Us Support
    Nice Insight/That’s Nice

    89 Fifth Avenue
    Fifth Floor
    New York
    NY 10003-3020

    New York – San Diego – Chicago
    London – Frankfurt – Shanghai

    Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

    © PHARMA’S ALMANAC 2021 Terms and Conditions